{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:56:56Z","timestamp":1785265016438,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A2B4012232"],"award-info":[{"award-number":["2016R1A2B4012232"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["02-2013-015"],"award-info":[{"award-number":["02-2013-015"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is the most common neurodegenerative disease characterized by memory loss and the presence of amyloid plaques and neurofibrillary tangles in the patients\u2019 brains. In this study, we investigated the alterations in metabolite profiles of the hippocampal tissues from 6, 8, and 12\u2009month-old wild-type (WT) and 5xfamiliar AD (5xFAD) mice, an AD mouse model harboring 5 early-onset familiar AD mutations, which shows memory loss from approximately 5\u2009months of age, by exploiting the untargeted metabolomics profiling. We found that nicotinamide and adenosine monophosphate levels have been significantly decreased while lysophosphatidylcholine (LysoPC) (16:0), LysoPC (18:0), and lysophosphatidylethanolamine (LysoPE) (16:0) levels have been significantly increased in the hippocampi from 5xFAD mice at 8\u2009months or 12\u2009months of age, compared to those from age-matched wild-type mice. In the present study, we focused on the role of nicotinamide and examined if replenishment of nicotinamide exerts attenuating effects on the reduction in dendritic spine density in hippocampal primary neurons from 5xFAD mice. Treatment with nicotinamide attenuated the deficits in spine density in the hippocampal primary neurons derived from 5xFAD mice, indicating a potential role of nicotinamide in the pathogenesis of AD. Taken together, these findings suggest that the decreased hippocampal nicotinamide level could be linked with AD pathogenesis and be a useful therapeutic target for AD.<\/jats:p>","DOI":"10.1186\/s13041-020-0565-x","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T10:02:47Z","timestamp":1581069767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Nicotinamide attenuates the decrease in dendritic spine density in hippocampal primary neurons from 5xFAD mice, an Alzheimer\u2019s disease animal model"],"prefix":"10.1186","volume":"13","author":[{"given":"Hyunju","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-9674","authenticated-orcid":false,"given":"Hye-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Youn","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"issue":"7","key":"565_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrn2420","volume":"9","author":"J Gotz","year":"2008","unstructured":"Gotz J, Ittner LM. Animal models of Alzheimer\u2019s disease and frontotemporal dementia. Nat Rev Neurosci. 2008;9(7):532\u201344.","journal-title":"Nat Rev Neurosci"},{"issue":"33","key":"565_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1556\/650.2019.31485","volume":"160","author":"A Albert","year":"2019","unstructured":"Albert A, Borbely K. Molecular imaging of Alzheimer's disease. Orv Hetil. 2019;160(33):1289\u201395.","journal-title":"Orv Hetil"},{"issue":"40","key":"565_CR3","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"key":"565_CR4","first-page":"1434","volume":"49","author":"YH Koh","year":"2019","unstructured":"Koh YH, Nguyen P, Osabutey AF, Choi BH, Kim AY. The regulation of neuroinflammation in brains of 5xFAD mice is underlying mechanisms of prevention of onset of Alzheimer's diseases by mature silkworm powders. Eur J Immunol. 2019;49:1434.","journal-title":"Eur J Immunol"},{"key":"565_CR5","doi-asserted-by":"publisher","unstructured":"Hayashi K, Hasegawa Y, Takemoto Y, Cao C, Mukasa A, Kim-Mitsuyama S. Enhanced oxidative stress contributes to worse prognosis and delayed neurofunctional recovery after striatal intracerebral hemorrhage in 5XFAD mice. Eur J Neurosci. 2019. https:\/\/doi.org\/10.1111\/ejn.14596.","DOI":"10.1111\/ejn.14596"},{"issue":"18","key":"565_CR6","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.4155\/bio-2018-0135","volume":"10","author":"MO Hurtado","year":"2018","unstructured":"Hurtado MO, Kohler I, de Lange EC. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies. Bioanalysis. 2018;10(18):1525\u201346.","journal-title":"Bioanalysis"},{"issue":"1","key":"565_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002482","volume":"15","author":"VR Varma","year":"2018","unstructured":"Varma VR, Oommen AM, Varma S, Casanova R, An Y, Andrews RM, et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study. PLoS Med. 2018;15(1):e1002482.","journal-title":"PLoS Med"},{"issue":"3","key":"565_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2010","unstructured":"He X, Huang Y, Li B, Gong CX, Schuchman EH. Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging. 2010;31(3):398\u2013408.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"565_CR9","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/j.1471-4159.1992.tb10994.x","volume":"59","author":"M Soderberg","year":"1992","unstructured":"Soderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G. Lipid composition in different regions of the brain in Alzheimer's disease\/senile dementia of Alzheimer's type. J Neurochem. 1992;59(5):1646\u201353.","journal-title":"J Neurochem"},{"issue":"9","key":"565_CR10","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","volume":"35","author":"P Liu","year":"2014","unstructured":"Liu P, Fleete MS, Jing Y, Collie ND, Curtis MA, Waldvogel HJ, et al. Altered arginine metabolism in Alzheimer's disease brains. Neurobiol Aging. 2014;35(9):1992\u20132003.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"565_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175369","volume":"12","author":"M van Gijsel-Bonnello","year":"2017","unstructured":"van Gijsel-Bonnello M, Baranger K, Benech P, Rivera S, Khrestchatisky M, de Reggi M, et al. Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: alleviation by pantethine. PLoS One. 2017;12(4):e0175369.","journal-title":"PLoS One"},{"issue":"12 Pt A","key":"565_CR12","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.bbadis.2014.09.014","volume":"1842","author":"R Gonzalez-Dominguez","year":"2014","unstructured":"Gonzalez-Dominguez R, Garcia-Barrera T, Vitorica J, Gomez-Ariza JL. Region-specific metabolic alterations in the brain of the APP\/PS1 transgenic mice of Alzheimer\u2019s disease. Biochim Biophys Acta. 2014;1842(12 Pt A):2395\u2013402.","journal-title":"Biochim Biophys Acta"},{"key":"565_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","volume":"102","author":"R Gonzalez-Dominguez","year":"2015","unstructured":"Gonzalez-Dominguez R, Garcia-Barrera T, Vitorica J, Gomez-Ariza JL. Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry. J Pharm Biomed Anal. 2015;102:425\u201335.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"565_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032737","volume":"7","author":"E Trushina","year":"2012","unstructured":"Trushina E, Nemutlu E, Zhang S, Christensen T, Camp J, Mesa J, et al. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One. 2012;7(2):e32737.","journal-title":"PLoS One"},{"key":"565_CR15","doi-asserted-by":"publisher","unstructured":"Schenck CA, Last RL. Location, location! Cellular relocalization primes specialized metabolic diversification. FEBS J. 2019. https:\/\/doi.org\/10.1111\/febs.15097.","DOI":"10.1111\/febs.15097"},{"issue":"1","key":"565_CR16","doi-asserted-by":"publisher","first-page":"e0168725","DOI":"10.1371\/journal.pone.0168725","volume":"12","author":"YR Huang","year":"2017","unstructured":"Huang YR, Zhong C, Lin HX, Wang JY. A method for finding metabolic pathways using atomic group tracking. PLoS One. 2017;12(1):e0168725.","journal-title":"PLoS One"},{"issue":"8","key":"565_CR17","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","volume":"1842","author":"E Trushina","year":"2014","unstructured":"Trushina E, Mielke MM. Recent advances in the application of metabolomics to Alzheimer's disease. Biochim Biophys Acta. 2014;1842(8):1232\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"565_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25years. EMBO Mol Med. 2016;8(6):595\u2013608.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"565_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of Alzheimer disease Neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012;71(5):362\u201381.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1\u20132","key":"565_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jns.2010.08.029","volume":"299","author":"FF Cruz-Sanchez","year":"2010","unstructured":"Cruz-Sanchez FF, Girones X, Ortega A, Alameda F, Lafuente JV. Oxidative stress in Alzheimer's disease hippocampus: a topographical study. J Neurol Sci. 2010;299(1\u20132):163\u20137.","journal-title":"J Neurol Sci"},{"issue":"9","key":"565_CR21","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1096\/fj.201700229R","volume":"31","author":"BA Berkowitz","year":"2017","unstructured":"Berkowitz BA, Lenning J, Khetarpal N, Tran C, Wu JY, Berri AM, et al. In vivo imaging of prodromal hippocampus CA1 subfield oxidative stress in models of Alzheimer disease and Angelman syndrome. FASEB J. 2017;31(9):4179\u201386.","journal-title":"FASEB J"},{"issue":"1","key":"565_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met. 1995;57(1):289\u2013300.","journal-title":"J Roy Stat Soc B Met"},{"issue":"45","key":"565_CR23","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","volume":"28","author":"KN Green","year":"2008","unstructured":"Green KN, Steffan JS, Martinez-Coria H, Sun XM, Schreiber SS, Thompson LM, et al. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving Sirtuin inhibition and selective reduction of Thr231-Phosphotau. J Neurosci. 2008;28(45):11500\u201310.","journal-title":"J Neurosci"},{"issue":"4","key":"565_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2174\/156720509788929237","volume":"6","author":"RC Petersen","year":"2009","unstructured":"Petersen RC. Early diagnosis of Alzheimer's disease: is MCI too late? Curr Alzheimer Res. 2009;6(4):324\u201330.","journal-title":"Curr Alzheimer Res"},{"key":"565_CR25","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1017\/cjn.2016.36","volume":"43","author":"KM Fiest","year":"2016","unstructured":"Fiest KM, Roberts JI, Maxwell CJ, Hogan DB, Smith EE, Frolkis A, et al. The prevalence and incidence of dementia due to Alzheimer\u2019s disease: a systematic review and meta-analysis. Can J Neurol Sci. 2016;43:S51\u201382.","journal-title":"Can J Neurol Sci"},{"key":"565_CR26","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1038\/tp.2011.55","volume":"1","author":"M Oresic","year":"2011","unstructured":"Oresic M, Hyotylainen T, Herukka SK, Sysi-Aho M, Mattila I, Seppanan-Laakso T, et al. Metabolome in progression to Alzheimer\u2019s disease. Transl Psychiatry. 2011;1:e57.","journal-title":"Transl Psychiatry"},{"key":"565_CR27","doi-asserted-by":"crossref","unstructured":"Weng WC, Huang WY, Tang HY, Cheng ML, Chen KH. The differences of serum metabolites between patients with early-stage Alzheimer\u2019s disease and mild cognitive impairment. Front Neurol. 2019;10.","DOI":"10.3389\/fneur.2019.01223"},{"issue":"1","key":"565_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","volume":"32","author":"P Belenky","year":"2007","unstructured":"Belenky P, Bogan KL, Brenner C. NAD+ metabolism in health and disease. Trends Biochem Sci. 2007;32(1):12\u20139.","journal-title":"Trends Biochem Sci"},{"key":"565_CR29","first-page":"S7","volume":"32","author":"HN Kim","year":"2017","unstructured":"Kim HN, Li H, Iyer S, Warren A, Manolagas S, Almeida M. The NAD(+) precursor nicotinamide riboside reverses the age-dependent decline of NAD(+) and Osteoprogenitor differentiation. J Bone Miner Res. 2017;32:S7.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"565_CR30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrm.2016.93","volume":"17","author":"MS Bonkowski","year":"2016","unstructured":"Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016;17(11):679\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"565_CR31","doi-asserted-by":"publisher","first-page":"e33246","DOI":"10.7554\/eLife.33246","volume":"7","author":"A Davila","year":"2018","unstructured":"Davila A, Liu L, Chellappa K, Redpath P, Nakamaru-Ogiso E, Paolella LM, et al. Nicotinamide adenine dinucleotide is transported into mammalian mitochondria. Elife. 2018;7:e33246.","journal-title":"Elife"},{"key":"565_CR32","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1194\/jlr.S092007","volume":"60","author":"M Romani","year":"2019","unstructured":"Romani M, Hofer DC, Katsyuba E, Auwerx J. Niacin: an old lipid drug in a new NAD+ dress. J Lipid Res. 2019;60:741\u20136.","journal-title":"J Lipid Res"},{"key":"565_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.pmbts.2017.11.012","volume":"154","author":"N Zhang","year":"2018","unstructured":"Zhang N, Sauve AA. Regulatory effects of NAD(+) metabolic pathways on Sirtuin activity. Prog Mol Biol Transl. 2018;154:71\u2013104.","journal-title":"Prog Mol Biol Transl"},{"issue":"9","key":"565_CR34","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1016\/j.neurobiolaging.2013.03.017","volume":"34","author":"D Liu","year":"2013","unstructured":"Liu D, Pitta M, Jiang H, Lee JH, Zhang G, Chen X, et al. Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession (vol 34, pg 1564, 2013). Neurobiol Aging. 2013;34(9):E3.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"565_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12017-009-8058-1","volume":"11","author":"D Liu","year":"2009","unstructured":"Liu D, Gharavi R, Pitta M, Gleichmann M, Mattson MP. Nicotinamide prevents NAD(+) depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD(+) consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med. 2009;11(1):28\u201342.","journal-title":"Neuromolecular Med"},{"issue":"5","key":"565_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1242\/dmm.028001","volume":"10","author":"VA Baldassarro","year":"2017","unstructured":"Baldassarro VA, Marchesini A, Giardino L, Calza L. Vulnerability of primary neurons derived from Tg2576 Alzheimer mice to oxygen and glucose deprivation: role of intraneuronal amyloid-beta accumulation and astrocytes. Dis Model Mech. 2017;10(5):671\u20138.","journal-title":"Dis Model Mech"},{"issue":"5","key":"565_CR37","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1523\/JNEUROSCI.2127-17.2017","volume":"38","author":"RP Kommaddi","year":"2018","unstructured":"Kommaddi RP, Das D, Karunakaran S, Nanguneri S, Bapat D, Ray A, et al. A beta mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer\u2019s disease. J Neurosci. 2018;38(5):1085\u201399.","journal-title":"J Neurosci"},{"issue":"6","key":"565_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jalz.2015.12.005","volume":"12","author":"MC de Wilde","year":"2016","unstructured":"de Wilde MC, Overk CR, Sijben JW, Masliah E. Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement. 2016;12(6):633\u201344.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"565_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-012-8173-2","volume":"14","author":"ZY Cai","year":"2012","unstructured":"Cai ZY, Yan LJ, Li KS, Quazi SH, Zhao B. Roles of AMP-activated protein kinase in Alzheimer\u2019s disease. Neuromolecular Med. 2012;14(1):1\u201314.","journal-title":"Neuromolecular Med"},{"issue":"2","key":"565_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11011-018-0374-4","volume":"34","author":"HC Feng","year":"2019","unstructured":"Feng HC, Wang CM, He W, Wu XJ, Li SJ, Zeng ZK, et al. Roflumilast ameliorates cognitive impairment in APP\/PS1 mice via cAMP\/CREB\/BDNF signaling and anti-neuroinflammatory effects. Metab Brain Dis. 2019;34(2):583\u201391.","journal-title":"Metab Brain Dis"},{"issue":"5","key":"565_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0197-4580(98)00083-9","volume":"19","author":"B Sims","year":"1998","unstructured":"Sims B, Powers RE, Sabina RL, Theibert AB. Elevated adenosine monophosphate deaminase activity in Alzheimer's disease brain. Neurobiol Aging. 1998;19(5):385\u201391.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"565_CR42","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1073\/pnas.81.12.3883","volume":"81","author":"UP Steinbrecher","year":"1984","unstructured":"Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low-density lipoprotein by endothelial-cells involves lipid-peroxidation and degradation of low-density lipoprotein phospholipids. P Natl Acad Sci-Biol. 1984;81(12):3883\u20137.","journal-title":"P Natl Acad Sci-Biol"},{"issue":"1\u20133","key":"565_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00213-008-1351-0","volume":"202","author":"EL Schaeffer","year":"2009","unstructured":"Schaeffer EL, Forlenza OV, Gattaz WF. Phospholipase A (2) activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology. 2009;202(1\u20133):37\u201351.","journal-title":"Psychopharmacology"},{"key":"565_CR44","doi-asserted-by":"publisher","first-page":"S292","DOI":"10.1016\/j.eurpsy.2008.01.631","volume":"23","author":"FB Mury","year":"2008","unstructured":"Mury FB, Barbosa NR, Defillipo PP, Mendes CT, Gattaz WF, Dias-Neto E. Memantine induces expression of PLA2 genes in rat brain: possible implications for reverse learning and memory of Alzheimer's disease patients. Eur Psychiatry. 2008;23:S292\u20133.","journal-title":"Eur Psychiatry"},{"issue":"1","key":"565_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1006\/nbdi.1996.0005","volume":"3","author":"DT Stephenson","year":"1996","unstructured":"Stephenson DT, Lemere CA, Selkoe DJ, Clemens JA. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis. 1996;3(1):51\u201363.","journal-title":"Neurobiol Dis"},{"key":"565_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neuroscience.2015.02.034","volume":"292","author":"AM Sheikh","year":"2015","unstructured":"Sheikh AM, Michikawa M, Kim SU, Nagai A. Lysophosphatidylcholine increases the neurotoxicity of Alzheimer\u2019s amyloid beta (1-42) peptide: role of oligomer formation. Neuroscience. 2015;292:159\u201369.","journal-title":"Neuroscience"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-020-0565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13041-020-0565-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-020-0565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T05:37:59Z","timestamp":1722404279000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-020-0565-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1186\/s13041-020-0565-x","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"assertion":[{"value":"29 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were carried out following the National Institutes of Health Guidelines for the Humane Treatment of Animals, with approval from the Institutional Animal Care and Use Committee of Seoul National University (IACUC No. SNU-131016-1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}